David Luedeker is Principal Scientist at Merck KGaA, Darmstadt, Germany working in the solid formulation R&D group supporting the development of novel excipients. David holds a Ph.D. in Chemistry from the University of Münster, dealing with the screening and analytics of pharmaceutical cocrystals and salts. He has more than 4 years of industrial experience in the pharmaceutical industry focusing on the characterization of active compounds and stabilization techniques for solid oral dosage formulations.